MAS1 and kidney disorder: To evaluate the contribution of Mas receptor for the renoprotective actions caused by the treatment with the AT1 antagonist Losartan, a dose of 10 mg/Kg of this medication was also given to Mas−/− and Mas+/+ mice with ADR-induced nephropathy.